טוען...
Efferent therapy in the first-line drug treatment of metastatic colorectal cancer
The aim of this study is to analyse the efficacy of efferent therapy (hemosorption) as part of drug treatment in patients with metastatic colorectal cancer (mCRC) based on the use of standard first-line chemotherapy combined with the bevacizumab biosimilar. The study included 54 patients with histol...
שמור ב:
| Main Authors: | , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Russo |
| יצא לאור: |
Remedium Group LLC
2018-07-01
|
| סדרה: | Медицинский совет |
| נושאים: | |
| גישה מקוונת: | https://www.med-sovet.pro/jour/article/view/2554 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|